Phase 3 Clinical Trial on the Efficacy and Safety of a New Therapy in the Treatment of Uncomplicated Influenza
Cerba Research performed a randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of a new therapy in the treatment of uncomplicated influenza.
Testing algorithms were complex as multiple PCR results had to be obtained from each sample, with only a single freeze-thaw cycle. Shipping the virology samples was also a challenge since maximum effort should be made to ship samples on the day, alternatively they would be stored and shipped refrigerated within 48 hours, or on dry ice later.
discover how our experts succeeded
Case Study – Phase 3 Clinical Trial on the Efficacy and Safety of a New Therapy in the Treatment of Uncomplicated Influenza
Reach out to our experts and discover how we can help you advance your clinical trialContact Us